These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 10997374

  • 1. Improvement of growth after growth hormone treatment in children who undergo liver transplantation.
    Rodeck B, Kardorff R, Melter M, Ehrich JH.
    J Pediatr Gastroenterol Nutr; 2000 Sep; 31(3):286-90. PubMed ID: 10997374
    [Abstract] [Full Text] [Related]

  • 2. Growth parameters and predictors of growth in short children with and without growth hormone (GH) deficiency treated with human GH: a randomized controlled study.
    Soliman AT, abdul Khadir MM.
    J Trop Pediatr; 1996 Oct; 42(5):281-6. PubMed ID: 8936959
    [Abstract] [Full Text] [Related]

  • 3. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM, Boersma B, de Muinck Keizer-Schrama SM, Nienhuis HE, Oostdijk W, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJ, Rikken B.
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Members of the German Study Group for Growth Hormone Treatment in Children with Renal Allografts.
    Tönshoff B, Haffner D, Mehls O, Dietz M, Ruder H, Blum WF, Heinrich U, Stöver B.
    Kidney Int; 1993 Jul; 44(1):199-207. PubMed ID: 7689125
    [Abstract] [Full Text] [Related]

  • 5. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
    Ballerini MG, Braslavsky D, Scaglia PA, Keselman A, Rodríguez ME, Martínez A, Freire AV, Domené HM, Jasper HG, Bergadá I, Ropelato MG.
    Horm Res Paediatr; 2017 Jul; 88(5):354-363. PubMed ID: 28926833
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency.
    Low LC, Kwan EY, Lim YJ, Lee AC, Tam CF, Lam KS.
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):359-63. PubMed ID: 7750189
    [Abstract] [Full Text] [Related]

  • 7. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C, Preece MA, Rose SJ, Fraser N, Rappaport R, Ranke MB, Savage MO.
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [Abstract] [Full Text] [Related]

  • 8. Growth after discontinuation of recombinant human growth hormone therapy in children with chronic renal insufficiency. The Genentech Cooperative Study Group.
    Fine RN, Brown DF, Kuntze J, Wooster P, Kohaut EE.
    J Pediatr; 1996 Dec; 129(6):883-91. PubMed ID: 8969731
    [Abstract] [Full Text] [Related]

  • 9. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [Abstract] [Full Text] [Related]

  • 10. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [Abstract] [Full Text] [Related]

  • 11. Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age.
    Schwarz HP, Walczak M, Birkholz-Walerzak D, Szalecki M, Nanu M, Woehling H, Schuck E.
    Adv Ther; 2016 Mar; 33(3):423-34. PubMed ID: 26886776
    [Abstract] [Full Text] [Related]

  • 12. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL, Lee PA, Gut R, Germak J.
    Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
    [Abstract] [Full Text] [Related]

  • 13. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
    Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Wit JM, Wolff ED, de Jong MC, Donckerwolcke RA, Abbad NC, Bot A, Blum WF.
    Lancet; 1991 Sep 07; 338(8767):585-90. PubMed ID: 1715501
    [Abstract] [Full Text] [Related]

  • 14. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
    Bakker NE, Lindberg A, Heissler J, Wollmann HA, Camacho-Hübner C, Hokken-Koelega AC, KIGS Steering Committee.
    J Clin Endocrinol Metab; 2017 May 01; 102(5):1702-1711. PubMed ID: 28323917
    [Abstract] [Full Text] [Related]

  • 15. Predicting the growth response to growth hormone in patients with intrauterine growth retardation.
    Frank GR, Cheung PT, Horn JA, Alfaro MP, Smith EP, Chernausek SD.
    Clin Endocrinol (Oxf); 1996 Jun 01; 44(6):679-85. PubMed ID: 8759180
    [Abstract] [Full Text] [Related]

  • 16. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
    Romer T, Saenger P, Peter F, Walczak M, Le Bouc Y, Khan-Boluki J, Berghout A.
    Horm Res; 2009 Jun 01; 72(6):359-69. PubMed ID: 19844125
    [Abstract] [Full Text] [Related]

  • 17. Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants: an interim report on five European studies.
    Johansson G, Sietnieks A, Janssens F, Proesmans W, Vanderschueren-Lodeweyckx M, Holmberg C, Sipilä I, Broyer M, Rappaport R, Albertsson-Wikland K.
    Acta Paediatr Scand Suppl; 1990 Jun 01; 370():36-42; discussion 43. PubMed ID: 2260456
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature.
    Ying YQ, Hou L, Liang Y, Wu W, Luo XP.
    Growth Horm IGF Res; 2018 Jun 01; 42-43():80-85. PubMed ID: 30343148
    [Abstract] [Full Text] [Related]

  • 19. Final height in non-growth hormone deficient children treated with growth hormone. The Italian Multicentre Study Group.
    Bernasconi S, Street ME, Volta C, Mazzardo G.
    Clin Endocrinol (Oxf); 1997 Sep 01; 47(3):261-6; discussion 267. PubMed ID: 9373443
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human growth hormone improves growth in children receiving glucocorticoid treatment after liver transplantation.
    Sarna S, Sipilä I, Rönnholm K, Koistinen R, Holmberg C.
    J Clin Endocrinol Metab; 1996 Apr 01; 81(4):1476-82. PubMed ID: 8636354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.